TAVR With the Novel Navitor Titan™ Transcatheter Heart Valve to Treat Aortic Stenosis Patients With Large Aortic Annuli

Cardiovasc Revasc Med. 2022 Jul:40S:120-122. doi: 10.1016/j.carrev.2022.03.028. Epub 2022 Apr 2.

Abstract

This case report describes the first transcatheter aortic valve replacement (TAVR) with the latest-generation Navitor Titan™ transcatheter heart valve (Abbott, USA) in a European patient with severe symptomatic aortic valve stenosis (AS). The Navitor Titan™ transcatheter heart valve has been developed to treat patients with large aortic annuli, namely aortic annulus perimeter 85 to 95 mm. In combination with the low profile FlexNav™ delivery system, the Navitor Titan™ valve offers the unique possibility to treat AS patients with large aortic annuli and suboptimal vascular access.

Keywords: Aortic valve stenosis; TAVR; Transcatheter valve implantation.

Publication types

  • Case Reports

MeSH terms

  • Aortic Valve / diagnostic imaging
  • Aortic Valve / surgery
  • Aortic Valve Stenosis* / diagnostic imaging
  • Aortic Valve Stenosis* / surgery
  • Heart Valve Prosthesis*
  • Humans
  • Prosthesis Design
  • Risk Factors
  • Transcatheter Aortic Valve Replacement*
  • Treatment Outcome